Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangioma, Capillary × Mupirocin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vascular Malformations 1 Surgical Wound Infection 1 Hemangioma, Capillary 1 Hemangioma 1

Interventions

Timolol 7 Propranolol 6 Lasers, Dye 3 Population Groups 2 Nadolol 2 Imiquimod 2 Atenolol 2 ziprasidone 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Surgery, Computer-Assisted 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Ophthalmic Solutions 1 Ointments 1 Nifedipine 1 Nafcillin 1 Mupirocin 1 Molindone 1 Methylprednisolone 1 Lurasidone Hydrochloride 1 Lasers, Solid-State 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡